Pronax

Muscolo - Skeletal System
Albania & Kosovo
No
Yes
Yes
SA01349
Pronax
500 mg
Film coated tablets
Naproxen
Box x 20
Film coated tablets - 500 mg Pronax contains the active substance naproxen which belongs to a group of medicines called nonsteroidal antiinflammatory … Read more

Film coated tablets - 500 mg

Pronax contains the active substance naproxen which belongs to a group of medicines called nonsteroidal antiinflammatory drugs (NSAIDs). It has antiinflammatory, analgesic, and antipyretic properties.

Pronax is indicated for the treatment of:

  • pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders;
  • dysmenorrhoea;
  • acute gout.

 

Recently viewed

Tablets - 300mg

Alopurin is a medicine which inhibits the formation of uric acid (uricostatic).

Alopurin is indicated:

Adults

  • in cases where blood uric acid values are 500 µmol/l (8.5mg/100 ml) and above, provided it is dietary unmanageable, or in clinical complications with hyperuricemic conditions, especially manifested gout, renal damage caused by uric acid (uratenephropathy),treatment and prevention of uric acid stones, and to prevent the formation of calcium oxalate stones in concomitant hyperuricemia;
  • in raised blood uric acid levels and increased excretion of uric acid in urine, e.g. in strong cell decay, radiation or chemotherapy (secondary hyperuricemia).

Tablets - 25 mg

Film coated tablets - 180 mg

 

Tablets – 100 mg

Alopurin is a medicine which inhibits the formation of uric acid (uricostatic).

Alopurin is indicated:

Adults

  • in cases where blood uric acid values are 500 µmol/l (8.5mg/100 ml) and above, provided it is dietary unmanageable, or in clinical complications with hyperuricemic conditions, especially manifested gout, renal damage caused by uric acid (urate nephropathy),treatment and prevention of uric acid stones, and to prevent the formation of calcium oxalate stones in concomitant hyperuricemia;
  • in raised blood uric acid levels and increased excretion of uric acid in urine, e.g. in strong cell decay, radiation or chemotherapy (secondary hyperuricemia).

Solution for injection - (0.1%) 1 mg/1 ml